Clinical Trials

Valneva SE, a specialty vaccine company, and Pfizer Inc. reported further positive Phase 2 data for their Lyme disease vaccine candidate, VLA15. Based on...

Moderna Starts Variant Specific Vaccine Trials After Pfizer

Clinical Trials

Moderna, the US biotech firm, has announced that it has initiated clinical trials of a booster that is especially designed to fight out the...

Autism clinical trials now open on the TrialWire Platform

Clinical Trials

TrialWire(TM) is pleased to announce new Autism (ASD) clinical studies are now available on the TrialWire Platform. More than 6 million people have used...

Valneva Announces Positive Lot-to-Lot Consistency Trial Results for its Single-Shot Chikungunya Vaccine Candidate

Clinical Trials

Valneva SE, a specialty vaccine company, announced positive topline results from the lot-to-lot Phase 3 trial of its single-shot chikungunya vaccine candidate, VLA1553. The...

CASI Pharmaceuticals And Bioinvent Announce CTA Approval For Clinical Study Of BI-1206 In NHL In China

Clinical Trials

CASI Pharmaceuticals, Inc., a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announces that the China National Medical Products...

The 6-Step Strategy for a Smart, Efficient Clinical Batch

Clinical Trials

For injectable medications, the shift from preclinical to clinical development is one of the most important transitions in the development cycle. It’s the point...

Agilex Biolabs Announced as Citeline Award Finalist for COVID-19 Vaccine Toxicology Preclinical Research

Clinical Trials

The Citeline Awards were created to recognize accomplishments across the biopharmaceutical industry, providing an opportunity for the industry to honor its highest achievers. Achievements...

Subscribe Our Newsletter

White Papers

Whitepapers

Clinical Trials

About us

Resources

Advertise

Subscribe